In the snow-covered mountains, man's best friend can quickly become man's best chance at survival. That's why, for decades, Colorado Rapid Avalanche Deployment has been training dogs and handlers to rise to the challenge.
In the snow-covered mountains, man's best friend can quickly become man's best chance at survival. That's why, for decades, Colorado Rapid Avalanche Deployment has been training dogs and handlers to rise to the challenge.
A recording of the presentation will be made accessible on the C-RAD website after the presentation.
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient s motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient s motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
Share this article
Share this article
STOCKHOLM, April 23, 2021 /PRNewswire/ The Patent and Market Court of Appeal at the Svea Court of Appeal partly confirms the judgment of the Patent and Market Court of 26 July 2019, which gave C-RAD the right to the invention described in the patent application entitled Ionizing radiation detecting device . The judgment from the Patent and Market Court of Appeal gives C-RAD the right to 50 percent of the invention as certain minor parts of the invention origins from Beomocular, a company in bankruptcy. C-RAD sued Beamocular in May 2017. The judgment of the Patent and Market Court of Appeal cannot be appealed. Both parties will carry their own legal cost.